Short Company profile

 

Sopharma AD (SFA) Sopharma AD convenes an extraordinary General Meeting of Shareholders on 05.12.2025 at 11:00 a.m. in Sofia, 5 Lachezar Stanchev Str., Sopharma Business Towers, Sopharma Event Center, with the following agenda: - Adoption of the 6-month financial report for the first half of 2025; - Selection of an auditor to express assurance on the company's sustainability report for 2025; - Changes to the company's articles of association; - Adoption of a decision to distribute the profit and pay an interim dividend based on the adopted 6-month financial report. Draft resolution: Distributes a 6-month gross dividend in the amount of 0.07 leva (0.03579 euros) per share from the profit realized according to the prepared 6-month financial report for the first half of 2025; - Adoption of a resolution to conclude a transaction within the scope of art. 114, para. 1, item 6 of the POSA; Proposal for a resolution: The IOSA authorizes the company's representatives to conclude a transaction within the scope of art. 114, para. 1, item 6 of the POSA according to the terms of the Motivated Report prepared by the Board of Directors included in the materials for the IOSA; - In the absence of a quorum, the meeting will be held on 09.01.2026 at 11:00 a.m. at the same place and with the same agenda. The right to vote at the GMS is exercised by persons registered as such with the right to vote in the central securities register 14 days before the date of the GMS, or as of 21.11.2025. The last date for concluding transactions with shares of this company on the Exchange, as a result of which the acquirer will be able to exercise the right to vote at the GMS, is 19.11.2025.

 

News	page 1 / 401   page

12.03.2026: Sopharma AD (SFA) Notification from Donev Investments Holding...
11.03.2026: Sopharma AD (SFA) Notification from Telso AD under Regulation...
10.03.2026: At a meeting of the Board of Directors of BSE AD under Minutes...
10.03.2026: Sopharma AD (SFA) Notification from Ognyan Donev under...
10.03.2026: At a meeting of the Bulgarian Stock Exchange Index Commission,...
10.03.2026: At a meeting of the Index Commission of the Bulgarian Stock...
09.03.2026: Sopharma AD (SFA) Notification from Telso AD under Regulation...
09.03.2026: Sopharma AD (SFA) On 05.03.2026, Sopharma AD sold 5,500...
09.03.2026: Sopharma AD (SFA) Notification from Telso AD under Regulation...
09.03.2026: Sopharma AD (SFA) Notification from Ognyan Donev under...